History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Cycle for Survival Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Office Phone:646-735-8121
E-mail:riedele@mskcc.org
Education:Columbia University

Elyn Riedel
Elyn Riedel, MA
Senior Research Biostatistician Manager, Consulting Service

Current Research Interests

Ms. Riedel's collaborations involve work with the Health Outcomes Group, Nuclear Medicine Service, and more recently with members of the Sarcoma Program Project. Various projects have included 1) influence of hospital and surgeon volume on outcomes following radical prostatectomy (using the SEER-Medicare linked databases), 2) effect of a low fat diet on PSA levels in men at risk for prostate cancer, 3) evaluation of the additional value of whole body FDG-PET over CT in the staging of patients with suspected metastatic colorectal carcinoma, and 4) assessment of prognostic factors in patients with low-grade oligodendroglioma.

Ms Riedel currently serves as Randomization Coordinator of the Biostatistics Service and is responsible for the design and maintenance of the treatment allocation schema for the Center's randomized protocols.

Selected Bibliography:

1. Yeung HWD, Cody HS III, Turlakow A, Riedel E, Fey J, Gonen M, Nunez R, Yeh SD, Larson SM. Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols. Journal of Nuclear Medicine 2001; 42(3):420-423.
[PubMed Abstract]

2. Ramos CD, Erdi YE, Gonen M, Riedel E, Yeung HWD, Macapinlac HA, Chisin R, Larson SM. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. European Journal of Nuclear Medicine 2001; 28(2):155-164.
[PubMed Abstract]

3. Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 2000; 54:1442-1448.
[PubMed Abstract]

4. Hudis C, Seidman A, Baselga J, Raptis G, Lebwohl D, Gilewski T, Moynahan M, Sklarin N, Fennelly D, Crown JP, Surbone A, Uhlenhopp M, Riedel E, Yao TJ, Norton L. Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy. Journal of Clinical Oncology 1999; 17(1):93-100.
[PubMed Abstract]

PrintEmail This Page